Editorial: Why the randomized controlled trial is still at the apex and the gold standard for evaluating new medical and surgical interventions
Year: 2025
Type: editorial
Abstract: Why the randomized controlled trial is still at the apex and the gold standard for evaluating new medical and surgical interventions
Source: Acta Orthopaedica
Authors: Aleksi Reito, Søren Overgaard
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $1,779
OpenAlex ID: W4416614198
